首页> 美国卫生研究院文献>Scientific Reports >Involucratusins A–H: Unusual Cadinane Dimers from Stahlianthus involucratus with Multidrug Resistance Reversal Activity
【2h】

Involucratusins A–H: Unusual Cadinane Dimers from Stahlianthus involucratus with Multidrug Resistance Reversal Activity

机译:Involucratusins A–H:来自Stahlianthus involucratus的异常卡丹烷二聚体具有多药耐药逆转活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Three novel cadinane dimers, involucratusins A–C (>1–>3), five unique nor-cadinane-dimers, involucratusins D–H (>4–>8), together with a known compound (>9) were isolated from the rhizomes of Stahlianthus involucratus. Their challenging structures and absolute configurations were determined by spectroscopic data, CD experimentation, chemical conversions and single-crystal X-ray diffraction. Compounds >1–>3 are unusual cadinane dimers with new connection and novel cores. Compound >4 is a unique nor-cadinane-dimer, and >5 and >6 are two pairs of hemiketal racemates with novel dinor-cadinane-dimer backbone. Compounds >7 and >8 represent unusual dodecanor-cadinane-dimer and tetradecanor-cadinane-dimer carbon skeletons, respectively. The possible biogenetic pathways of >1–>8 were proposed, involving nucleophilic addition, SN2 nucleophilic displacement, [3 + 3] benzannulation, oxidative cleavage, decarboxylation, and oxidative phenol coupling reactions. Multidrug resistance (MDR) reversal activity assay of the isolates were evaluated in doxorubicin-resistant human breast cancer cells (MCF-7/DOX). The combined use of these novel cadinane dimers at a concentration of 10 μM increased the cytotoxicity of doxorubicin by 2.2–5.8-fold. It is the first report about the MDR reversal activity of cadinane dimers.
机译:三个新颖的卡丹烷二聚体,involucratusins A–C(> 1 – > 3 ),五个独特的正丹烷二聚物,involucratusins D–H(> 4 – > 8 )与已知化合物(> 9 )一起从Stahlianthus involucratus的根茎中分离出来。它们的挑战性结构和绝对构型由光谱数据,CD实验,化学转化和单晶X射线衍射确定。化合物> 1 – > 3 是不寻常的卡丹烷二聚体,具有新的连接和新颖的核。化合物> 4 是一种独特的正丹宁二聚体,而> 5 和> 6 是两对具有新的dinor-cadinane-dimer主链的半体消旋体。化合物> 7 和> 8 分别代表不寻常的十二碳烷-二甲基-二聚体和十四碳烷-二甲基-二聚体碳骨架。提出了> 1 – > 8 可能的生物发生途径,涉及亲核加成,SN2亲核置换,[3 + 3]苯并环,氧化裂解,脱羧和氧化酚偶联反应。在耐阿霉素的人乳腺癌细胞(MCF-7 / DOX)中评估了分离物的多药耐药性(MDR)逆转活性。这些新型卡丹烷二聚体以10μm的浓度联合使用可使阿霉素的细胞毒性提高2.2-5.8倍。这是关于卡丹烷二聚体的MDR逆转活性的第一份报告。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号